Characterization of Myelodysplastic Syndromes (MDS) With T-cell Large Granular Lymphocyte Proliferations (LGL)
|
Jun 2020
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders
|
May 2012
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia
|
Feb 2013
|
Leukemia
|
aplastic anemia
|
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
|
Feb 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
What causes aplastic anaemia?
|
Apr 2023
|
Leukemia
|
aplastic anemia
|
Therapy-related myelodysplastic syndromes-specific risk stratification: Are we putting the cart before the horse?
|
Jul 2017
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias
|
Feb 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study
|
Oct 2023
|
Leukemia
|
aplastic anemia
|
The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood - a prospective study by EWOG-MDS.
|
Jun 2013
|
Leukemia
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Rethinking clinical trial endpoints in myelodysplastic syndromes.
|
Jan 2019
|
Leukemia
|
myelodysplastic syndromes (MDS)
|